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http:WHAT THIS STUDY ADDS
The aim of this study was to evaluate the safety and effectiveness of combined proximal endografting with distal
restrictive bare stents (RBSs) in the endovascular treatment of acute complicated Stanford type B aortic dis-
sections. Studies focusing speciﬁcally on re-dissection at the distal edge of the stent graft and the subsequent
aortic remodeling are lacking. Thus, this study was initiated to explore the feasibility of using RBS and their
effectiveness in preventing stent induced distal re-dissection and enhancing aortic remodeling.Objective: This study evaluates the safety and efﬁcacy of pre-placement of a distal bare stent as an adjunct to
thoracic endovascular aortic repair (TEVAR) in the setting of complicated acute Stanford type B aortic dissection
(cTBAD).
Methods: The records of all patients diagnosed with cTBAD at the institution between 2010 and 2013 were
reviewed. Indications for the pre-placement of a distal bare stent included symptomatic malperfusion and/or
radiological evidence of true lumen collapse. Computed tomography angiography was performed post-
operatively to assess aortic remodeling.
Results: 148 patients were treated for cTBAD: 113 patients (76.4%) were treated with standard TEVAR and 35
(23.6%) were treated by combined proximal TEVAR with pre-placement of an adjunctive distal bare stent.
Primary technical success was 95.9%. The 30 day mortality rate was 4.1% and was not different between groups.
The 30 day morbidity included transient renal failure (10.1%), endoleak (7.4%), and paraplegia (2.7%), and was
not different between groups. The mean follow up was 10 months (range 2e12 months). No late stent
complications were observed; patients with an adjunctive bare stent had less distal re-dissection (0% vs. 15%;
p ¼ .01) and fewer endovascular re-interventions (5.7% vs. 20.4%; p ¼ .04). At 1 year, patients treated with
TEVAR and an adjunctive distal bare stent had increased true lumen volume (166 vs. 110 mL; p ¼ .022),
decreased false lumen volume (60 vs. 90 mL; p ¼ .043), and increased complete false lumen thrombosis in the
thoracic (76.5% vs. 29.5%; p < .001) and abdominal (20.6% vs. 3.8%; p ¼ .002) segments.
Conclusions: Combined pre-placement of a distal bare stent as an adjunct to proximal TEVAR to treat cTBAD
restricts oversizing of the distal stent graft, reducing the potential for distal true lumen collapse and visceral
malperfusion, and improving remodeling of the dissected thoracic aorta. Long-term follow up and prospective
studies are needed to assess the overall effectiveness of this treatment strategy.
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Acute type B aortic dissection accounts for 25e40% of all
aortic dissections.1 Although the majority of patients with
uncomplicated disease can be treated with intensive med-
ical management, thoracic endovascular aortic repair
(TEVAR) in addition to best medical treatment (BMT) is
associated with improved 5 year aorta speciﬁc survival and
delayed disease progression as well as dramatic improve-
ment in aortic remodeling.2,3 Complicated acute type B
aortic dissection (cTBAD), such as aortic rupture or visceral
or limb malperfusion, is associated with 40e100% mortal-
ity, mandating aggressive operative intervention.4 TEVAR is
associated with improved early outcomes relative to con-
ventional therapy,5e7 and has become the preferred ther-
apeutic option in most specialized aortic centers, with many
now considering TEVAR with BMT as the ﬁrst line therapy
for cTBAD.8,9 Despite reduced mortality associated with
TEVAR compared with open surgery, TEVAR still remains
controversial due to concerns over long-term durability and
the need for re-interventions.
There are two important mechanisms that may
contribute to reduced durability and increased re-
interventions after technically successful TEVAR. First, size
mismatch between the distal end of the stent graft and the
remarkably small diameter of a compressed distal true
lumen (TL) may contribute to relatively excessive oversizing
that contributes to distal endoleak or re-dissections, with
stent induced distal re-dissection (SIDR) associated with
mortality of approximately 25%.10 Second, technically suc-
cessful TEVAR can result in incomplete repair of the aorta
distal to the stent graft, with the distal aorta failing to
remodel and incomplete false lumen (FL) thrombosis,11
predisposing the patient to late complications such asFigure 1. (A,B) Preprocedure computed tomographic scan showing a
lumen. (A) Three dimensional reconstruction. (B) Abdominal aorta sh
showing (C) initial release of the distal bare stent (arrow) at the distal
(arrow) in the proximal thoracic aorta. (E) Computed tomographic scan
stent (blue arrow) and distal bare stent (white arrow) with re-expansirepeat dissection, aneurysmal degeneration, and rupture.
One potential solution is to deploy a bare stent distal to the
stent graft. Mossop and coworkers12 ﬁrst reported the
Provisional ExTension To Induce COmplete Attachment
(Petticoat) concept that may induce positive aortic remod-
eling with TL expansion and FL thrombosis as well as
preservation of the visceral arteries.13e16
Although the Petticoat concept of an adjunctive distal
bare stent was appreciated, it was a worry that if initial
deployment of the main body landed the distal end of the
stent graft in an area of diseased aorta, then further aortic
dissection or other structural damage could result prior to
placement of the distal bare stent. As such, the distal bare
stent was placed ﬁrst, at the intended distal landing zone,
followed by the proximal covered stent graft. It was hy-
pothesized that placement of the distal bare stent prior to
the main stent graft would prevent the excessive force of
the distal end of the stent graft on the aorta, prevent early
aortic wall damage, late SIDR, and promote TL expansion
and FL thrombosis. The purpose of this retrospective study
was to describe the >3 year initial clinical experience using
this technique for the management of acute cTBAD.MATERIALS AND METHODS
Patient characteristics
The 3rd Xiang-ya Hospital Ethics Committee approved this
retrospective study and waived the need for individual
patient consent. Of the 180 consecutive patients diagnosed
with acute TBAD at the hospital from 2010 to 2013, 32 had
uncomplicated dissections, received conservative treat-
ment, and were excluded from this study, whereas the
other 148 patients had cTBAD and were treated withcute type B dissection with false lumen compression of the true
owing collapsed true lumen. (C,D) Digital subtraction angiography
landing zone and then (D) subsequent deployment the stent graft
6 months after the procedure showing the position of the covered
on of the true lumen and obliteration of the false lumen.
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cated if they met one or more of the following criteria:
branch vessel obstruction; impending rupture deﬁned as an
enlarged aortic diameter in the dissected region with evi-
dence of hemothorax and no active contrast extravasation
in the computed tomography angiography (CTA) images;
resistant hypertension; or persistent pain or symptoms.
Indications for the use of the distal bare stent technique
were clinical evidence of malperfusion and/or radiologic
evidence of complete TL collapse.
Data collection and follow up
Data were recorded including operative details, technical
success, and early and midterm outcomes, including
endoleak, retrograde dissection, aortic rupture, stroke,
paraparesis or paraplegia, renal failure, bowel ischemia, 30
day and midterm mortality, and freedom from re-
intervention. Multiplanar CTA scans and physical examina-
tion and laboratory studies were obtained before the pro-
cedure and during follow up and reviewed.
Device and endovascular procedure
The proximal and distal landing zones and sizing of the stent
graft were determined using pre-operative thoraco-
abdominal CTA with three dimensional multiplanar recon-
struction (Fig. 1A,B). The diameter of the adjunctive bare
stent (Sinus-XL stent, OptiMed, Ettlingen, Germany) was
selected using the greatest diameter of the TL at the
intended distal edge of the stent graft; the bare stent was
not oversized in comparison to the aorta. The stent was
positioned proximally to anticipate 30e40 mm of overlap
with the distal end of the proximal covered stent graft. The
length of distal bare stent was determined by the distal
extension of the dissection and any branch vessel or TL
compromise.
All procedures were performed in the interventional suite
under general anesthesia. A 4F pigtail catheter was placed
percutaneously via the left brachial artery to localize the
oriﬁce of the left subclavian artery (LSA) and perform
angiography. Angiography was performed to conﬁrm the
primary entry tear and re-entry sites. In order to obtain an
adequate proximal landing zone, some patients required an
extra-anatomic carotidesubclavian bypass prior to stent
graft deployment or a chimney technique (with at least
2 cm overlap) to preserve the LSA. Open femoral cut downs
were used to facilitate catheter based access to the TL and
the aortic arch. An aortogram was performed to assess
patency of the visceral vessels and their origin from the TL
or FL. A super-stiff Lunderquist pre-curved guidewire (Cook,
Inc., Bloomington, IN, USA) was placed over a pigtail cath-
eter navigated in the TL under both ﬂuoroscopic and
transesophageal echocardiography (TOE) guidance, to
ensure correct positioning of the stiff wire in the TL. After
evaluating the descending aorta, the distal bare stent was
ﬁrst placed into the compressed TL and deployed at the
predetermined position (Fig. 1C) allowing 30e40 mm for
overlap with the proximal covered stent. Aortography wasrepeated to reassess stent expansion before introducing the
large sheath for the proximal stent graft, and then the
proximal stent graft was delivered over the super-stiff
guidewire to the predetermined position and released,
leaving its distal end partially within the bare stent (Fig. 1D).
Four proximal stent graft systems were used: Zenith TX2
(Cook, Bjaeverskov, Denmark); Relay (Bolton Medical Inc,
Sunrise, FL, USA); Hercules (Microport, Shanghai, China),
and Talent (Medtronic, Santa Rosa, CA, USA). No post-
deployment ballooning was used. Completion aortography
was then performed to ensure coverage of the proximal
entry tear and visualization of side branches.
All patients had cerebrospinal ﬂuid drainage, systemic
steroid therapy and pharmacological support to maintain
mean arterial pressure (MAP) between 90 and 100 mmHg
during the procedure.
Primary technical success was deﬁned as endograft
deployment without type I or III endoleak and absence of
open surgical conversion or death within 24 hours of the
operation.17Assessment of aortic remodeling
CTA was used to assess aortic remodeling at 3, 6, and 12
months after the procedure (Fig. 1E). Successful remodeling
was deﬁned by TL re-expansion with concomitant complete
thrombosis and retraction of the FL. Aortic remodeling was
assessed separately for the descending thoracic aorta and
the abdominal aorta (divided at the level of the celiac
trunk). The TL and FL volumes were measured for the entire
descending thoracic and abdominal aorta from the innom-
inate artery to the aortic bifurcation. The status of the FL
was also qualitatively assessed on CTA as patent, partially
thrombosed, or completely thrombosed in the descending
thoracic aorta and abdominal aorta.Statistical analysis
Data are expressed as mean  standard deviation. Com-
parisons of continuous variables were performed using the
Student t test for independent variables. Differences were
considered signiﬁcant if two sided p < .05. All statistical
analyses were conducted using SPSS 17.0 software (SPSS
Inc, Chicago, IL, USA). Data within individual literature re-
ports was reviewed and the weighted means calculated
without statistical comparison.RESULTS
Of the 148 consecutive patients treated at the hospital for
cTBAD from 2010 to 2013, 113 patients were repaired with
a thoracic stent graft using routine TEVAR technique; 35
patients were treated using combined proximal TEVAR with
pre-placement of an adjunctive distal bare stent. De-
mographic details and pre-operative risk factors of these
patients are described in Table 1. Most frequently, patients
had refractory chest pain and hypertension as their indi-
cation for treatment; patients treated with pre-placement
of an adjunctive bare stent more frequently had TL
Table 1. Patient demographics and pre-operative risk factors.
TEVAR (n ¼ 113) TEVAR with bare stent (n ¼ 35) p
Age (yrs) 43  5 42  12 .24
Male sex 92 (81.4%) 30 (85.7%) .56
Hypertension 110 (97.3%) 34 (97.1%) .95
Diabetes 10 (8.8%) 2 (5.7%) .55
Coronary artery disease 13 (11.5%) 6 (17.1%) .38
COPD 10 (8.8%) 4 (11.4%) .65
Renal insufﬁciency 7 (6.2%) 2 (5.7%) .92
Prior aortic surgery 15 (13.3%) 6 (17.1%) .57
ASA classiﬁcation .97
2 48 (42.4%) 16 (45.7%)
3 70 (61.9%) 22 (62.9%)
4 8 (7.1%) 3 (8.6%)
Mean TL diameter (mm)
Aortic arch 31.6  2.3 30.3  1.6 .96
Proximal descending aorta 17.6  5.9 16.7  8.9 .42
Distal descending aorta 13.5  5.8 10.0  3.5 .17
Abdominal aorta 10.5  3.7 9.4  5.3 .32
Indications
Branch vessel compromise 18 (15.9%) 12 (34.3%) .02a
Renal dynamic malperfusion 10 (8.8%) 6 (17.1%) .17
Small bowel dynamic malperfusion 4 (3.5%) 4 (11.4%) .07
Limb dynamic malperfusion 4 (3.5%) 2 (5.7%) .57
True lumen collapse 6 (5.3%) 15 (42.8%) <.0001a
Impending rupture 20 (18%) 5 (14.3%) .64
Refractory chest pain 103 (92%) 32 (91.4%) .96
Refractory hypertension 99 (88%) 30 (85.7%) .77
TEVAR ¼ thoracic endovascular aortic repair; COPD ¼ chronic obstructive pulmonary disease; ASA ¼ American Society of
Anesthesiologists; TL ¼ true lumen.
a Signiﬁcant, < .05.
Modiﬁed Petticoat Technique 453collapse (42.8%) or branch vessel malperfusion (34.3%)
(Table 1).
Pre-placement of an adjunctive distal bare stent did not
signiﬁcantly increase the mean ﬂuoroscopy time, total time,
or contrast volume compared with the standard TEVAR
procedure (Table 2). Coverage of the LSA was performed in
27 patients to enable complete coverage of the proximal
entry tear, after conﬁrmation of adequate collateral cere-
bral circulation, and was not different between groups
(Table 2). Other adjunctive devices and procedures included
use of an Amplatzer occluder (St. Jude Medical, Minneap-
olis, MN, USA) to treat persistent subclavian type II endo-
leak, carotidesubclavian bypass to obtain an adequate
proximal landing zone, and chimney grafts to maintain the
LSA, with similar use of these adjuncts between groups
(Table 2). None of the patients required complementary
arterial branch stenting. The mean bare stent diameter was
22.5 mm (range 18e26 mm) and the mean length was
70.7 mm (range 60e80 mm); the mean proximal thoracic
stent graft diameter was 33.6 mm (range 26e38 mm) and
the mean length was 152.4 mm (range 120e200 mm). Four
stent graft systems were used, with device selection at the
discretion of the surgeon (Table 2).
Primary technical success, for example endograft
deployment without type I or III endoleak and absence of
open surgical conversion or death within 24 hours of the
operation, was achieved in 142 of 148 patients (95.9%)(Table 3). Five of the technical failures occurred in patients
with TEVAR alone; there were four patients with type IA
endoleak and one patient with a retrograde acute type A
aortic dissection requiring emergent sternotomy. The single
technical failure among patients treated with TEVAR and
adjunctive bare stent was due to FL rupture in the
abdominal aorta distal to the bare stent, despite an intact
proximal intimal ﬂap between the TL and FL; autopsy
showed that FL perfusion was likely to be from collateral
ﬂow or re-entry tears fed by a partially thrombosed thoracic
FL. There were no technical difﬁculties with performing
TEVAR after deployment of the distal bare stent. The 30 day
mortality rate was 4.1% and was not different between
groups (Table 3); all of these deaths were related to aortic
rupture. The 30 day morbidity included transient renal
failure (10.1%), endoleak (7.4%), and paraplegia (2.7%), and
was again not different between groups.
The incidence of endoleak (<30 days) after standard
TEVAR was 7.9%. Three of these nine patients had an
asymptomatic type II endoleak not requiring any interven-
tion, and six patients had type I endoleak with residual ﬂow
from the proximal entry tear requiring proximal extension
of the stent graft. In patients treated with TEVAR and pre-
placement of an adjunctive distal bare stent the incidence
of endoleak was 5.7%, which was not signiﬁcantly different
from patients treated with standard TEVAR (Table 3). One
patient had a type I endoleak treated with an overlapping
Table 2. Procedure characteristics.
TEVAR (n ¼ 113) TEVAR with bare stent (n ¼ 35) p
Stent graft devices
Zenith TX2 30 (26.5%) 10 (28.6%) .81
Relay 8 (7.1%) 2 (5.7%) .91
Talent 12 (10.6%) 5 (14.3%) .77
Hercules 63 (55.8%) 18 (51.4%) .65
Median diameter (mm) 34 33.6
Median length (mm) 148 152.4
Bare stent
Sinus-XL 0 (0%) 35 (100%) <.001a
Median diameter (mm) e 22.5
Median length (mm) e 70.7
Procedure details
Mean ﬂuoroscopy time (min) 22  4 27  7 .64
Average contrast volume (mL) 100  7 105  15 .81
Procedure time (min) 50  18 70  15 .34
Coverage LSA
Total coverage 20 (17.7%) 7 (20%) .76
Partial coverage 68 (60.2%) 20 (57.1%) .75
Adjunctive procedures
Amplatzer occluder 8 (7.1%) 1 (2.8%) .61.
Carotidesubclavian bypass 14 (12.4%) 5 (14.3%) .99
Chimney graft 20 (17.7%) 3 (8.6%) .19
Distal stent graft extension 0 (0%) 0 (0%)
Renal artery bare stent 0 (0%) 0 (0%)
Mesenteric artery bare stent 0 (0%) 0 (0%)
Ilio-femoral artery bare stent 0 (0%) 0 (0%)
Mean length of hospital stay (days) 6.3  2.3 5.2  3.2 .78
TEVAR ¼ thoracic endovascular aortic repair; LSA ¼ left subclavian artery.
a Signiﬁcant, <.05.
454 H. He et al.proximal endograft, and one patient had a large type II
endoleak originating from the LSA that was treated by coil
embolization.
Follow up after 30 days was complete in all patients. The
mean follow up was 10 months (range 2e12 months). No
mechanical stent graft complications such as angulation,Table 3. Patient outcomes after TEVAR.
TEVAR (n ¼ 113)
Technical success 108 (95.6%)
30 day mortality 5 (4.4%)
30 day morbidity
Endoleak 9 (7.9%)
Aortic rupture 5 (4.4%)
Stroke 0 (0%)
Paraplegia 3 (2.7%)
Acute renal failure 10 (8.8%)
>30 day mortality 3 (2.7%)
>30 day morbidity
Permanent dialysis 8 (7.1%)
Late aortic rupture 3 (2.7%)
SIDR 17 (15%)
Secondary intervention
Surgical 4 (3.5%)
Endovascular 23 (20.4%)
TEVAR ¼ thoracic endovascular aortic repair; SIDR ¼ stent graft induc
a Signiﬁcant, <.05.dislodgement, or migration were observed. There were no
late aortic ruptures in patients treated with adjunctive bare
stents but this was not statistically signiﬁcantly less than
rupture after standard TEVAR (0% vs. 2.7%; p ¼ .38)
(Table 3). The incidence of SIDR was signiﬁcantly lower in
the TEVAR with distal bare stent group (0% vs. 15%;TEVAR with bare stent (n ¼ 35) p
34 (97.1%) .98
1 (2.8%) .46
2 (5.7%) .66
1 (2.8%) .46
0 (0%) e
1 (2.8%) .95
5 (14.3%) .35
0 (0%) .38
0 (0%) .11
0 (0%) .38
0 (0%) .01a
0 (0%) .26
2 (5.7%) .04a
ed distal re-dissection.
Table 4. Quantitative assessment of aortic remodeling after TEVAR.
TEVAR, mL (n ¼ 113) TEVAR with bare stent, mL (n ¼ 35) p
Pre-operative Thoracic TL 78  16 62  20 .432
FL 200  25 240  35 .567
Abdominal TL 22  19 24  18 .763
FL 90  15 79  22 .637
12-month follow up Thoracic TL 110  28 166  30 .022a
FL 90  27 60  32 .043a
Abdominal TL 40  24 61  13 .274
FL 60  16 48  22 .462
TEVAR ¼ thoracic endovascular aortic repair; TL ¼ true lumen; FL ¼ false lumen.
a Signiﬁcant, <.05.
Table 5. Qualitative assessments of the false lumen after TEVAR.
TEVAR (n ¼ 113) TEVAR with bare
stent (n ¼ 35)
T test p
Pre-operative Thoracic Patent 53 (50.5%) 16 (47.1%) 0.12 .7291
Partially thrombosed 52 (49.5%) 18 (52.9%)
Completely thrombosed 0 (0%) 0 (0%)
Abdominal Patent 76 (73.8%) 24 (70.6%) 0.145 .9301
Partially thrombosed 27 (25.7%) 9 (26.5%)
Completely thrombosed 2 (1.9%) 1 (2.9%)
12-month follow up Thoracic Patent 0 (0%) 0 (0%) 23.4 <0.001a
Partially thrombosed 74 (70.5%) 8 (23.5%)
Completely thrombosed 31 (29.5%) 26 (76.5%)
Abdominal Patent 32 (30.5%) 4 (11.8%) 12.62 .0018a
Partially thrombosed 69 (65.7%) 23 (67.6%)
Completely thrombosed 4 (3.8%) 7 (20.6%)
TEVAR ¼ thoracic endovascular aortic repair.
a Signiﬁcant, <.05.
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signiﬁcantly lower in this group as well (5.7% vs. 20.4%;
p ¼ .04).
Among the patients treated with TEVAR alone, the most
common cause for secondary interventions was SIDR
(n ¼ 17), and all required distal stent placement; among the
18 patients (15.9%) who had branch vessel compromise
pre-operatively, 14 vessels maintained patency and four
patients required open surgical fenestration for persistent
malperfusion. Eight of the 10 patients that developed acute
renal failure progressed to permanent dialysis.
In patients treated with TEVAR and an adjunctive distal
bare stent there were no cases of late aortic rupture or
SIDR. No conversion to open surgical repair occurred within
1 year. All of the malperfused visceral branch vessels
remained patent; no clinical signs or symptoms of abdom-
inal organ malperfusion were observed. None of the pa-
tients with early acute renal failure required permanent
dialysis or underwent secondary interventions such as renal
artery stent placement.
Of the 34 patients treated with technical success using a
distal bare stent, post-operative CTA showed reconstitution
of the collapsed TL in all cases (Fig. 1E), abolition of distal
malperfusion, no new signs of interim complications, no
progression of aortic expansion, and no visualized ﬂow
obstruction to the abdominal side branches. At 1 year,patients treated with TEVAR and an adjunctive distal bare
stent had increased TL volume (166 vs. 110 mL; p ¼ .022)
and decreased FL volume (60 vs. 90 mL; p ¼ .043) in the
thoracic aorta, with trends towards the same in the
abdominal aorta (Table 4). Patients treated with an
adjunctive distal bare stent also had increased complete FL
thrombosis in the thoracic (76.5% vs. 29.5%; p < .001) and
abdominal (20.6% vs. 3.8%; p ¼ .002) segments (Table 5).DISCUSSION
In this series of 148 consecutive patients with cTBAD, TEVAR
is associated with high rates of technical success and very
low mortality and morbidity. Pre-placement of an adjunc-
tive distal bare stent is not associated with additional
adverse events within 1 year of follow up, and is associated
with reduced SIDR and secondary endovascular in-
terventions as well as increased TL expansion and FL
shrinkage in the thoracic aorta. These results compare
favorably with other series (Table 6).5,14e16,18e29
The International Registry of Acute Aortic Dissection
(IRAD) data indicates that cTBAD patients with malperfusion
or impending rupture undergoing open repair suffer sig-
niﬁcant morbidity and mortality.30 The emergence of
endovascular treatment has signiﬁcantly altered the in-
dications for traditional open surgery to treat aortic
Table 6. Results of TEVAR without or with distal bare stent for management of acute complicated type aortic dissection.
Author Year n Mean
follow
up
(month)
30 day
mortality
(%)
Aortic
rupture
(%)
Retrograde
dissection
(%)
Stroke
(%)
Paraplegia
(%)
Renal
failure
(%)
Bowel
ischemia (%)
Adjunctive distal
procedure (%)
True lumen
expansion
(%)
False lumen
thrombosis
(%)
TEVAR
Conrad19 2009 33 12 12 6 9 3 12 0 0 0 N/A 88
Khoynezhad20 2009 28 36 11 0 4 3 0 10 7 4 N/A 88
Shu5 2010 45 36 4 0 0 0 0 4 2 0 56 56
White21 2011 85 12 11 14 0 9 9 9 4 5 N/A N/A
Hofferberth14 2012 23 49 9 9 N/A 4 0 22 17 43 N/A 46
Qin22 2012 124 53 0 0 2 1 1 N/A NA 14 N/A N/A
Feng23 2013 180 39 3 2 3 N/A 1 N/A N/A 9 N/A N/A
Ehrich24 2013 29 26 17 7 3 7 0 0 13 20 N/A N/A
Hanna25 2014 50 34 0 0 2 2 2 8 N/A 14 NA 72
Hea 2015 113 10 4.4 7.1 1 0 2.7 8.8 0 0 100 29.5
Meanb 5.0 4.2 2.2 2.8 2.6 7.7 3.9 8.7 87.5 54.4
TEVAR with bare stent
Nienaber16 2006 12 12 0 0 0 0 0 0 0 0 100 75
Mossop26 2007 6 18 0 0 0 0 0 0 0 0 N/A N/A
Mellissano15 2012 25 38 0 0 0 0 4 20 0 24 100 N/A
Hofferberth14 2012 11 57 3 0 0 5 0 13 0 19.3 N/A 72
Liu27 2013 33 36 0 0 0 0 0 3 0 0 N/A N/A
Feng23 2013 86 45 1 1 0 N/A 1 N/A N/A 4 N/A N/A
Alsac28 2014 15 8 0 0 0 7 7 13 7 0 N/A 71
Lombardi29 2014 55 24 6 2 4 11 2 11 2 0 100 38
Hea 2015 35 10 2.8 2.8 0 0 2.8 14.3 0 0 100 76.5
Meanb 2.0 1.1 0.8 4.0 1.8 10.6 1.1 4.2 100.0 58.8
TEVAR ¼ thoracic endovascular aortic repair; N/A ¼ not available.
a This report.
b Weighted mean.
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Modiﬁed Petticoat Technique 457dissection,18 with TEVAR emerging as a preferred choice to
treat cTBAD.20,31 Although TEVAR allows less invasive aortic
repair, the optimal device to treat dissection is not currently
known and remains quite controversial. An important
consideration for device selection includes long-term
morbidity, with SIDR being a serious concern.32e34 In
addition, persistent FL perfusion with partial thrombosis can
lead to aneurysmal degeneration, rupture, or re-dissection,
with high mortality and morbidity.35,36 Many of these
concerns may be related to particular devices, or they may
be related to the technique of TEVAR itself.
As a potential solution for long-term morbidity after
TEVAR, the approach of extension with a distal uncovered
stent, such as described in the Petticoat or Staged Total
Aortic and Branch Vessel Endovascular (STABLE) studies, has
been introduced to facilitate restoration of distal perfusion
and to enhance aortic remodeling in the abdominal
aorta.12e16 Initial reports from the single arm, multicenter
STABLE trial have demonstrated favorable clinical and
anatomic outcomes at 1 year.29 However, the value of
adjunctive distal bare stent placement is not currently
established, with centers performing TEVAR for cTBAD both
without and with a distal bare stent (Table 6).5,14e16,18e29 In
these recent reports, TEVAR with an adjunctive distal bare
stent is associated with reduced mortality, aortic rupture,
retrograde dissection, fewer use of adjunctive distal endo-
vascular procedures, and increased TL expansion (Table 6). It
is suggested that use of an adjunctive distal bare stent im-
proves the efﬁcacy of TEVAR in the management of cTBAD.
However, there are differences between the technique
described here and the Petticoat concept: ﬁrstly, the pur-
poses are different, as the Petticoat technique is designed
to enhance distal anchoring of the thoracic stent graft.
However, it was hypothesized that the distal stent tech-
nique limits the expansion of the stent graft in the dissected
aorta, reducing acute aortic injury and later SIDR; 0% SIDR
was observed, compared to 15% after standard TEVAR
(Table 3). Second, the distal bare stent was placed ﬁrst,
prior to deployment of the main thoracic stent graft. Third,
great care is taken to ensure overlap between the distal
bare stent and the thoracic stent graft in order to prevent
late endoleaks or other complications. It is believed that the
addition of the distal bare stent stabilizes the dissection ﬂap
and restores the normal diameter of the distal aorta,
reversing TL collapse and enhancing FL thrombosis. In
addition, initial placement of the bare stent signiﬁcantly
reduces visceral malperfusion and reduces FL pressure,
enhancing restoration of blood ﬂow in the visceral and
lower extremity arteries, potentially reducing the risk of
complications such as dialysis, bowel ischemia, or
ischemiaereperfusion injury.37 Comparison of patients
treated with pre-placement of a distal bare stent with pa-
tients anatomically suitable but not receiving a distal stent
would be helpful to establish the true value of this tech-
nique, but this comparison is not possible in this retro-
spective review.
Similar to PETTICOAT, placement of a distal bare stent
was not associated with complete FL thrombosis in allcases15; perfusion of the FL in the abdominal aorta was still
present in 11.8% of the patients (Table 5). Since FL
thrombosis is related to freedom from long-term dissection
related mortality,36 techniques to enhance FL thrombosis
are critical to achieve long-term durability of TEVAR.
Fenestrated or branched stent grafts may enhance FL
exclusion and thrombosis,28,38 but use of this technology in
the dissected aorta is very limited and poses particular
challenges. Use of a covered stent distally, covering the
entire thoracic aorta to the celiac trunk, could increase the
rate of neurological complications such as spinal cord
ischemia. Therefore, residual FL perfusion was managed
conservatively in stable patients and progressive aneu-
rysmal degeneration or worsening TL perfusion have not
been observed. However, longer follow up is still needed.
This study has the typical limitations of any retrospective
study; the small sample size and relatively short follow up
prevented long-term follow up and subset analysis. In
addition, the lack of accepted endpoints and guidelines to
treat partial FL thrombosis prevent clear assessment of
achieving clinical success; however, none of the patients
required additional therapy for persistent FL perfusion. It is
also likely that some selection bias was present, as noted by
the high percentage of cases that were complicated and
required TEVAR, as the center is a tertiary center for cTBAD
patient referral. Finally, the use of 6e8 cm long distal
adjunctive bare stents extends the stent only 3e5 cm
distally into the aorta, given the overlap between the stent
graft and the distal bare stent; use of longer distal bare
stents might yield different clinical results.
CONCLUSIONS
Using an adjunctive distal bare stent with TEVAR to treat
acute cTBAD appears to be a reasonable approach to
reduce the risk of SIDR and intimal rupture, improve distal
TL perfusion, and reduce visceral malperfusion, and may
improve remodeling of the dissected aorta. Long-term
follow up and prospective studies are needed to assess
the overall effectiveness of this treatment strategy.
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